The UAE’s pharmaceutical market presents significant growth opportunities for multinational drug makers. In particular, the expansion of private healthcare coverage and the modernization of health infrastructure will continue to drive prescription market growth.
At present, most of the world’s top multinational pharmaceutical companies have set up regional headquarters and manufacturing plants in the UAE, and we are privileged to call some of them our partners.
Marwan Abdulaziz Janahi, Executive Director of Dubai Science Park
Expenditure on pharmaceuticals in 2020, from USD 344 in 2019
Value of pharmaceutical products imported into the UAE in 2020
Value of pharmaceutical sales in 2020
The UAE's projected spending on generic drugs by 2030, which translates to a CAGR of 7.3%
The shift of market preferences towards generic drugs and other medical products may shape the future trajectory of the UAE pharmaceuticals market, as companies increasingly seek to manufacture generics in an effort to keep pace with modern market dynamics. As such, there is good scope for manufacturing businesses in pharmaceuticals, as well as adhesive dressings, wadding and gauzes, gel preparations for surgery, first aid boxes and kits, and orthodontic fittings.
In addition to the fact that the UAE has a burgeoning domestic pharmaceutical manufacturing industry, many international pharmaceutical companies have set up in the country. Some of these companies – such as Pfizer and Janssen EMEA (the pharmaceutical arm of Johnson & Johnson) – have decided to make the UAE the site of their regional headquarters.
With the advent of newer improved minimal invasive procedures and advancements in high-risk treatments, the demand for innovative pharmaceutical products has increased. Continued support from the pharma sector to learned professionals and well-equipped healthcare facilities is essential in ensuring the best patient experiences.
Taher Shams, Managing Director, Zulekha Healthcare Group